TTRX
Turn Therapeutics Inc.
$7.12
+0.27 (+3.94%)
At close · Jul 2
Market Cap
$212.09M
Shares
29,788,040
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.12
Open$6.94
Day$6.83–7.32
52W$2.57–26.50
Avg vol 30d56K
Short int31K · 0.1% float · 1.0d
Short vol54%
Last earningsMay 11, 2026
DataOct 2025–Jul 2026
Filing10-Q · May 11
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 50-day avg
+40% above
◦
RSI (14)
67 · neutral
+
MACD trend
positive
◦
52-week position
19% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50/200-day averages unavailable
−
Institutional flow
-9% holders QoQ · +3 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.10% of float · ▼ -51.9% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
20 holders — 13F breadth
Fundamentals
Fair
−
EPS growth
−71% Y/Y
+
Balance sheet
net cash $4.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 50-day avg
+40% above
Bullish
RSI (14)
67 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
19% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-9% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.10% of float · ▼ -51.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $3
Now $7 · 19%
52-wk high $27
vs 50-day avg +40%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TTRX
this stock
Turn Therapeutics Inc.
|
$212.09M | +80.7% | — | — | 0.1% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TTRX | +4.4% | +18.3% | +53.1% | -2.5% | +80.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +3.0% | +19.5% | +45.1% | -2.2% | +71.5% |